| Literature DB >> 32033425 |
Laura C Miller1, Damarius S Fleming1,2, Kelly M Lager1.
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major respiratory pathogen of swine that has become extremely costly to the swine industry worldwide, often causing losses in production and animal life due to their ease of spread. However, the intracellular changes that occur in pigs following viral respiratory infections are still scantily understood for PRRSV, as well as other viral respiratory infections. The aim of this study was to acquire a better understanding of the PRRS disease by comparing gene expression changes that occur in tracheobronchial lymph nodes (TBLN) of pigs infected with either porcine reproductive and respiratory syndrome virus (PRRSV), porcine circovirus type 2 (PCV-2), or swine influenza A virus (IAV-S) infections. The study identified and compared gene expression changes in the TBLN of 80 pigs following infection by PRRSV, PCV-2, IAV-S, or sham inoculation. Total RNA was pooled for each group and time-point (1, 3, 6, and 14 dpi) to make 16 libraries-analyses are by Digital Gene Expression Tag Profiling (DGETP). The data underwent standard filtering to generate a list of sequence tag raw counts that were then analyzed using multidimensional and differential expression statistical tests. The results showed that PRRSV, IAV-S and PCV-2 viral infections followed a clinical course in the pigs typical of experimental infection of young pigs with these viruses. Gene expression results echoed this course, as well as uncovered genes related to intersecting and unique host immune responses to the three viruses. By testing and observing the host response to other respiratory viruses, our study has elucidated similarities and differences that can assist in the development of vaccines and therapeutics that shorten or prevent a chronic PRRSV infection.Entities:
Keywords: IAV-S; PCV-2; PRRSV; differential expression; immune response; lymph node
Year: 2020 PMID: 32033425 PMCID: PMC7168592 DOI: 10.3390/pathogens9020099
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1(a) Rectal temperature of pigs before and after challenge. Shown are mean rectal temperatures and standard error bars for each of the four groups. Pigs inoculated with porcine reproductive and respiratory syndrome virus (PRRSV) had a biphasic increase in rectal temperature with an initial peak at 2 dpi and a second sustained increase between 6 to 14 dpi. Pigs inoculated with porcine circovirus type 2 (PCV-2) had only a slightly increased rectal temperature from 10 to 14 dpi. Pigs inoculated with influenza A virus (IAV-S) had a transiently increased rectal temperature from 1 to 2 dpi; (b) body weight of pigs before and after challenge. Shown are mean body weights and standard error bars for each of the four groups.
Lung macroscopic lesion scores.
| Group | 3 dpi | 6 dpi | 14 dpi |
|---|---|---|---|
| Sham | 0.34 ± 0.3 | 0.14 ± 0.1 | 0 ± 0 |
| PCV-2 | 0.11 ± 0.1 | 1.36 ± 1.2 | 1.04 ± 0.6 |
| PRRSV | 5.27 ± 1.6 | 8.60 ± 3.4 | 57.1 ± 7.8 |
| IAV-S | 8.96 ± 1.4 | 31.5 ± 2.0 | 1.30 ± 0.5 |
Notes: PCV-2: porcine circovirus type 2; PRRSV: porcine reproductive and respiratory syndrome virus; IAV-S: influenza A virus.
Virus detection by qRT-PCR.
| Tissue | Treatment Group | Virus Tested for | 0 dpi | 1 dpi | 3 dpi | 6 dpi | 14 dpi |
|---|---|---|---|---|---|---|---|
| Serum | Control | PCV-2 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| Serum | Control | PRRSV | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| Serum | Control | IAV-S | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| Serum | PCV-2 | PCV-2 | 0/5 | 4/5 | 0/5 | 0/5 | 0/5 |
| Serum | PRRSV | PRRSV | 0/5 | 5/5 | 5/5 | 5/5 | 5/5 |
| Serum | IAV-S | IAV-S | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| BALF | Control | PCV-2 | 0/5 | 0/5 | 0/5 | 0/5 | |
| BALF | Control | PRRSV | 0/5 | 0/5 | 0/5 | 0/5 | |
| BALF | Control | IAV | 0/5 | 0/5 | 0/5 | 0/5 | |
| BALF | PCV-2 | PCV-2 | 4/5 | 5/5 | 4/5 | 4/5 | |
| BALF | PRRSV | PRRSV | 3/5 | 5/5 | 5/5 | 5/5 | |
| BALF | IAV-S | IAV-S | 0/5 | 1/5 | 1/5 | 0/5 | |
| TBLN | Control | PCV-2 | 0/5 | 0/5 | 0/5 | 0/5 | |
| TBLN | Control | PRRSV | 0/5 | 0/5 | 0/5 | 0/5 | |
| TBLN | Control | IAV-S | 0/5 | 0/5 | 0/5 | 0/5 | |
| TBLN | PCV-2 | PCV-2 | 2/5 | 3/5 | 3/5 | 4/5 | |
| TBLN | PRRSV | PRRSV | 5/5 | 5/5 | 5/5 | 5/5 | |
| TBLN | IAV-S | IAV-S | 0/5 | 1/5 | 0/5 | 0/5 |
Figure 2Venn diagram intersection of PRRSV, PCV-2, and IAV-S. (a) Intersection of Differentially Expressed Gene (DEG) in response to PCV-2, PRRSV, and IAV-S infection. A Venn diagram was applied to the expression data to elucidate the intersecting and unique genes expressed by the host in response to the viruses. (b) Breakdown of DEG by treatment.
List of DEGs response shared across all three viruses. All genes statistically significant at Q <= 0.1.
| Gene Name | PRRSV (Log2FC) | IAV-S (Log2FC) | PCV-2 (Log2FC) | Biological Function(s) |
|---|---|---|---|---|
|
| 1.21 | 0.81 | 0.51 | Cellular energy homeostasis and hematopoiesis |
|
| −1.51 | −1.58 | −1.00 | Negative regulation of autophagy; cadherin binding |
|
| 1.64 | 1.75 | 0.92 | Positive regulation of cytokine production involved in inflammatory response, positive regulation of leukocyte chemotaxis |
|
| 1.34 | 1.00 | 0.66 | Apoptotic process, modulates cell-cell and cell-matrix interactions; T cell costimulation; positive regulation of viral entry into host cell; positive regulation of I-kappaB kinase/NF-kappaB signaling |
| 2.17 | 2.53 | 0.86 | N/A | |
| 2.94 | 2.13 | 1.12 | N/A | |
|
| 1.41 | 1.33 | 0.73 | Negative regulation of apoptotic process, response to wounding, |
|
| 1.14 | 0.96 | 0.78 | Viral process |
|
| −0.85 | −0.93 | −0.52 | Antioxidant enzyme, cadherin binding; regulation of NIK/NF-kappaB signaling; natural killer cell activation |
|
| 1.34 | 1.06 | 0.6 | N/A |
|
| −0.82 | −0.99 | −0.63 | Autophagy; regulation of cytokinesis |
|
| 0.87 | 1.25 | 0.64 | Critical in cartilage for sulfation of proteoglycans and matrix organization, regulation of membrane potential |
List shows the intersecting genes between PRRSV and PCV-2 infections. All genes were statistically significant at Q <= 0.1.
| Gene Name | PRRSV (Log2FC) | PCV-2 (Log2FC) | Biological Function(s) |
|---|---|---|---|
|
| 1.90 | 1.03 | Transcriptional coactivator in RNA pol-II transcription, cholesterol-dependent gene regulation |
|
| 1.70 | 0.72 | Encodes an essential conserved subunit of RNA poly-I, II, and III |
|
| 1.26 | 0.79 | Late endosome to vacuole transport via multivesicular body sorting pathway |
|
| 1.15 | 0.58 | Regulation of canonical Wnt signaling, TGF-B receptor, and folate binding pathways |
|
| 1.15 | 0.67 | Protein phosphorylation, protein serine/threonine kinase activity |
|
| 1.12 | 0.51 | Nuclear export, negative regulator of TGF-Beta signaling |
|
| 1.08 | 0.65 | Protects cells from reactive oxygen species (ROS) and DNA damage-induced apoptosis; autophagy |
|
| 0.99 | 0.64 | protein-protein interactions |
|
| 0.93 | 0.54 | Component of the nucleolar small nuclear ribonucleoprotein particles (snoRNP), ribosome synthesis |
|
| 0.86 | 0.41 | Regulates the GDP-GTP exchange reaction, involved cellular trafficking in organelles |
|
| 0.83 | 0.49 | Focal adhesion disassembly |
|
| −0.59 | −0.43 | Structural constituent of ribosome, cytoplasmic translation |
|
| −0.87 | −0.50 | N/A |
|
| −0.92 | −0.47 | Helps form co-repressor complexes involved in transcriptional silencing, histone binding |
|
| −1.06 | −0.60 | Transmembrane protein |
|
| −1.08 | −0.55 | Actin and Integrin binding; T-cell activation, Extracellular matrix disassembly |
|
| −1.10 | −0.62 | Binds to CD4 for repression of T-cell activation, stimulatory activity of CD4, antigen receptor-mediated signaling |
|
| −1.17 | −0.47 | Membrane trafficking regulation, endosome sorting and recycling |
|
| −1.21 | −0.67 | Extracellular matrix organization, positive regulation of apoptotic process |
|
| −1.29 | −0.69 | N/A |
|
| −1.34 | −0.70 | Regulation of membrane delivery during cytokinesis, exocytosis |
|
| −1.45 | −0.52 | Rac GTPase binding, apoptotic process, viral process |
|
| −1.51 | −0.55 | Involved in cell cycle regulation and proliferation, RNA binding |
|
| −1.52 | −0.54 | Immune response, transcriptional activator, SMAD binding |
|
| −1.62 | −0.74 | Plasma membrane regeneration and repair, phospholipid binding, cellular response to heat |
|
| −1.75 | −0.95 | N/A |
|
| −1.76 | −0.73 | Regulation of complement-dependent cytotoxicity, homophilic cell adhesion via plasma membrane adhesion molecules; negative regulation of inflammatory response |
|
| −1.76 | −0.73 | Wnt signaling pathway, metallocarboxypeptidase activity |
|
| −1.76 | −1.15 | Membrane trafficking, immune functions |
|
| −1.91 | −0.68 | Focal adhesion, integrin activation, cell-cell communication |
|
| −2.00 | −0.64 | Ubiquitin protein ligase binding, negative regulation of BMP signaling pathway |
|
| −2.03 | −0.59 | Collagen formation, SMAD binding, extracellular matrix organization |
|
| −2.24 | −0.77 | Cell binding, cell signaling, and cytoskeletal organization, leukocyte migration |
|
| −2.38 | −0.76 | Rho GTPase binding |
|
| −2.38 | −1.00 | Extracellular matrix structural constituent, collagen binding, damage associated molecular pattern signaler (DAMPs) |
|
| −2.82 | −1.37 | MAP kinase activity, cellular response to amino acid stimulus |
|
| −3.61 | −1.12 | Protein binding |
List shows the intersecting genes between PRRSV and IAV-S infections. All genes were statistically significant at Q <= 0.1.
| Gene Name | PRRSV (Log2FC) | IAV-S (Log2FC) | Biological Function(s) |
|---|---|---|---|
|
| −1.09 | −1.09 | Palmitoyl-(protein) hydrolase activity, regulation of dendritic spine maintenance |
|
| −2.19 | −1.97 | Receptor for C-C type chemokines; bind dendritic cell- and T cell-activated chemokines; immune response, chemotaxis |
|
| −2.59 | −2.46 | Catalyzes the formation of acetyl-CoA and oxaloacetate, neutrophil degranulation, positive regulation of cellular metabolic process |
|
| 2.17 | 2.14 | Encoded protein can bind specifically to and inhibit the activity of hepatitis B virus; interleukin-12-mediated signaling pathway |
|
| 2.07 | 1.37 | Antimicrobial chemokine involved in immunoregulatory and inflammatory processes; Monocyte, neutrophil, and lymphocyte chemotaxis, chronic inflammatory response |
|
| 0.72 | 1.54 | Type-I transmembrane glycoprotein found on the surface of thymocytes, T lymphocytes and a subset of B lymphocytes; may be involved in T cell proliferation. T cell costimulation, apoptotic signaling pathway, scavenger receptor activity |
|
| −3.08 | −2.81 | May be important in development and homeostasis of the inner ear and retina, actin filament organization |
|
| −0.69 | −1.54 | Encodes one of the enzymes required for cellular nucleic acid biosynthesis, nucleoside monophosphate kinase activity |
|
| −1.12 | −0.98 | Cell adhesion |
|
| 1.45 | 1.24 | Contributes to translation initiation factor activity, regulation of translational initiation |
|
| 1.00 | 1.04 | Involved in cell proliferation, cell-cell interactions and function as a tumor suppressor, negative regulation of cell proliferation |
|
| 1.38 | 1.60 | Transcription factor, negative regulation of transcription by RNA polymerase II, |
|
| −1.50 | −1.36 | Oxidation-reduction process, cellular response to interleukin-4, cadherin binding |
|
| 1.35 | 0.99 | Regulation of macroautophagy, antimicrobial humoral immune response mediated by antimicrobial peptide, positive regulation of cytokine secretion |
|
| 2.79 | 2.54 | Double-strand break repair via break-induced replication, double-strand break repair via break-induced replication |
|
| 2.55 | 2.93 | Oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; role in metabolism |
|
| 2.88 | 2.48 | Defense response to virus, negative regulation of type I interferon production, ISG15-protein conjugation, ubiquitin-protein transferase activity |
|
| 1.08 | 1.25 | Regulates integrin-mediated signal transduction, MAPK cascade, cell-matrix adhesion, negative regulation of cardiac muscle cell apoptotic process |
|
| 1.62 | 1.57 | Protein O-linked glycosylation via serine |
|
| 0.77 | 0.73 | Mitochondrial electron transport, cytochrome c to oxygen |
|
| −2.60 | −2.15 | Integral component of membrane |
|
| 0.83 | 1.26 | Protein binding, cell volume homeostasis |
|
| 2.33 | 2.00 | MAP kinase activity, activated by various environmental stresses and proinflammatory cytokines, roles of in stress related transcription and cell cycle regulation, as well as in genotoxic stress response |
|
| 0.92 | 1.62 | Transcriptional regulator |
|
| 1.21 | 1.47 | Deubiquitinase, apoptotic process, Lys48-specific deubiquitinase activity |
|
| 0.89 | 1.23 | T cell proliferation, neutrophil degranulation |
|
| 1.30 | 1.24 | Transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding |
|
| 1.50 | 1.65 | Viral process, structural constituent of nuclear pore |
|
| 1.12 | 1.56 | CENP-A containing nucleosome assembly, protein binding |
|
| 1.40 | 1.19 | Gene may be involved in inflammation and immune response, inflammatory response, negative regulation of T cell proliferation, heparan sulfate proteoglycan binding |
|
| 1.01 | 0.83 | Pre-mRNA processing factor, mRNA splicing, via spliceosome |
|
| −3.25 | −2.43 | Cellular response to lipopolysaccharide, cellular response to tumor necrosis factor, mRNA splicing, via spliceosome |
|
| 1.52 | 1.57 | Transferase activity, phosphatidylserine biosynthetic process |
|
| 1.07 | 1.26 | Phagosome-lysosome fusion, neutrophil degranulation, antigen processing and presentation of exogenous peptide antigen via MHC class II (ALL HUMAN) |
|
| −1.37 | −1.22 | Regulation of mRNA processing |
|
| 1.11 | 1.32 | Binding ATP and may help promote cell survival; DNA damage response, detection of DNA damage |
|
| −0.71 | −1.15 | rRNA processing |
|
| −1.16 | −1.67 | Regulation of transcription by RNA polymerase II, cellular response to leukemia inhibitory factor |
|
| 2.25 | 2.90 | Intracellular protein transport, phosphatidylinositol binding |
|
| −3.49 | −3.29 | Actin filament organization, cytoskeletal adaptor activity |
|
| 1.42 | 1.15 | N/A |
|
| 1.08 | 1.00 | Removal of introns from precursor tRNAs, tRNA splicing, via endonucleolytic cleavage and ligation |
|
| 3.30 | 1.75 | Role may be to protect hypoxic cells from apoptosis, cell redox homeostasis, negative regulation of apoptotic process, neutrophil degranulation |
|
| 1.29 | 1.12 | Positive regulation of NF-kappaB transcription factor activity, activation of MAPK activity, positive regulation of I-kappaB kinase/NF-kappaB signaling |
|
| −2.66 | −2.57 | Positive regulation of cell-matrix adhesion, integrin binding |
|
| 1.13 | 0.82 | Positive regulation of fat cell differentiation, positive regulation of protein phosphorylation |
Figure 3Reactome of over-represented pathways effected by gene expression changes based on the PRRSV/PCV-2 intersection from the Venn diagram (Figure 2). The scale measures the collective effect of the expressed genes in that pathway with green corresponding to upregulated and red corresponding to downregulated pathways. This is based only on S.scrofa pathways.
Figure 4Reactome of over-represented pathways effected by gene expression changes based on the PRRSV/IAV-S intersection from the Venn diagram (Figure 2).The scale measures the collective effect of the expressed genes in that pathway with green corresponding to upregulated and red corresponding to downregulated pathways. This is based only on S.scrofa pathways.
Figure 5Multiquery G.O. Analysis. Manhattan plot showing G.O. enrichment. The X-axis are the G.O. functional terms colored by category. Each colored dot represents a G.O. term. The Y-axis are the adjusted –log10 p-values. Figure shows the differences in the (a) PRRSV/IAV-S and (b) PRRSV/PCV2 gene sets with focus on (c) terms unique or statistically significant to the PRRSV/IAV-S grouping. MF: Molecular Function; BP: Biological process; CC: Cellular component; MIRNA: MicroRNA; HP: Human Phenotype.
Figure 6Multiquery G.O. Analysis. Manhattan plot showing G.O. enrichment. The X-axis are the G.O. functional terms colored by category. Each colored dot represents a G.O. term. The Y-axis are the adjusted –log10 p-values Figure shows the differences in the (a) PRRSV/IAV-S and (b) PRRSV/PCV2 gene sets with focus on (c) terms unique to or statistically significant to the PRRSV/PCV-2 grouping. MF: Molecular Function; BP: Biological process; CC: Cellular component; MIRNA: MicroRNA; HP: Human Phenotype Ontology.